Autophagy£¨×ÔÊÉ£©£¬Õâ¸öµ¥´ÊÀ´×ÔÏ£À°×ֵġ°self¡±ºÍ¡°eat¡±£¬ÊÇ´æÔÚÓÚÕæºËÉúÎïÖÐÒ»Öָ߶ȱ£ÊصĴúл¹ý³Ì£¬²ÎÓëÁ˵÷½Úϸ°ûÎïÖʵĺϳɣ¬½µ½âºÍÖØÐÂÀûÓÃÖ®¼äµÄ´úлƽºâ¡£ÓÉÓÚ½üÄêÀ´Ô½À´Ô½¶àµÄÑо¿·¢ÏÖϸ°û×ÔÊÉÔÚÐí¶à¼²²¡£¬Èç°©Ö¢ºÍÉñ¾­ÍËÐÐÐÔ¼²²¡ÖаçÑÝÁËÖØÒª½ÇÉ«£¬Òò´ËÒ²³ÉΪÁËÒ»¸öÈȵãÑо¿ÁìÓò¡£

½üÆÚÀ´×ÔÕã½­´óѧҽѧԺ£¬¸½ÊôµÚÒ»Ò½ÔºµÄÑо¿ÈËÔ±·¢±íÁËÌâΪ¡°VpS34 Acetylation Controls Its Lipid Kinase Activity and the Initiation of Canonical and Non-canonical Autophagy¡±µÄÎÄÕ£¬Ö¸³öÁËÒ»ÖֹؼüµÄϸ°û×ÔÊÉ×÷ÓÃÒò×ӵ碌î·Ö×Ó»úÖÆ£¬¼´VpS34µÄÒÒõ£»¯ÊÇÆä¼¤»îµÄÖØÒªÒªËØ£¬p300ÒÀÀµÐÔVpS34ÒÒõ£»¯/È¥ÒÒõ£»¯ÊÇVpS34¼¤»îµÄ¹Ø¼üÉúÀíÌõ¼þ£¬ÕâÖÖÐÞÊε÷¿ØÁ˵äÐÍÐÔ×ÔÊɺͷǵäÐÍÐÔ×ÔÊɵįô¶¯¡£

ÕâÒ»Ñо¿³É¹û¹«²¼ÔÚ9ÔÂ21ÈÕµÄMolecular CellÔÓÖ¾ÉÏ£¬ÎÄÕµÄͨѶ×÷ÕßΪÕã½­´óѧÇóÊÇÌØÆ¸½ÌÊÚÁõΰ²©Ê¿£¬Áõΰ²©Ê¿2007ÄêÊÜÆ¸Õã½­´óѧҽѧԺ½ÌÊÚ¡¢²©Ê¿Éúµ¼Ê¦£¬½¨Á¢ÁËÒÔϸ°ûÆ÷½á¹¹ºÍ¹¦ÄÜΪÑо¿ÖÐÐĵÄϸ°ûÆ÷ÉúÎïѧʵÑéÊÒ¡£Ä¿Ç°µÄÖ÷ÒªÑо¿·½ÏòÊÇϸ°û×ÔÊɵķÖ×Óϸ°ûѧ»úÖÆºÍ×ÔÊÉÓëÖ×ÁöµÄ·¢Éú¡£

ϸ°û×ÔÊɹý³ÌÖУ¬Ï¸°ûÄÚ²¿µÄһЩԪ¼þ»á·¢Éú½µ½âºÍºÏ³É£¬ÒÔÈ·±£ÕûÌåµÄÉú´æ¡£´Ëǰ¹ÜÀ¤Á¼½ÌÊÚµÈÈË·¢ÏÖAMpKÄÜÒÔ²»Í¬µÄ·½Ê½£¬µ÷¿ØÒ»ÖÖ³ÆÎªVps34£¨The class III phosphoinositide 3-kinase£©¼¤Ã¸¼Ò×岻ͬµÄ¸´ºÏÎһЩVps34ø²ÎÓëÁËÕý³£Ï¸°ûµÄÄÒÅÝÔËÊ䡪¡ªÏ¸°ûÖÐÒ»ÖÖÖØÒªµÄ·Ö×ÓÔËÊ䣬»¹ÓÐһЩVps34¸´ºÏÎïÔò²ÎÓëÁËϸ°û×ÔÊÉ¡£¹Ü½ÌÊÚÓëÆäͬÊÂÃÇ·¢ÏÖ£¬AMpKÄÜÒÖÖÆÄÇЩδ²ÎÓëϸ°û×ÔÊɵÄø£¬¶ø¼¤»î²ÎÓëϸ°û×ÔÊɵÄVps34ø¡£´ËºóËûÃÇÓÖ½Òʾ³öÒ»Ìõͨ¹ýULK1¼¤»î´Ù×ÔÊÉ֬øVpS34£¬ÓÕµ¼×ÔÊɵķÖ×Ó»úÖÆ¡£

µ«ÊÇÆù½ñΪֹ£¬³ýÁËVpS34Óëµ÷¿Øµ°°×Ï໥×÷Óã¬Ðγɸ´ºÏÎïÖ®Í⣬¿ÆÑ§¼ÒÃDz¢²»Á˽âÆä¼¤»îµÄ·Ö×Ó»úÖÆ¡£ÔÚ×îÐÂÕâÏîÑо¿ÖУ¬Ñо¿ÈËÔ±·¢ÏÖVpS34»á±»ÒÒõ£×ªÒÆÃ¸p300ÌØÒìÐÔÒÒõ£»¯£¬p300½éµ¼µÄÒÒõ£»¯ÄÜÒÖÖÆVpS34»îÐÔ¡£¶øÇÒK771´¦µÄÒÒõ£»¯Ö±½Ó½µµÍÁËVpS34¶ÔÆäµ×ÎïpIµÄÇ׺ÍÁ¦£¬K29µÄÒÒõ£»¯Ò²×è°­ÁËVpS34-Beclin 1ºËÐĸ´ºÏÎïµÄÐγÉ¡£

ͬʱÑо¿ÈËÔ±»¹·¢ÏÖp300µÄʧ»î»áÓÕµ¼VpS34È¥ÒÒõ£»¯£¬Óɴ˲úÉúpI3pºÍϸ°û×ÔÊÉ¡£ÔÚ¿Õ¸¹Ð¡ÊóÖУ¬¸ÎÔà×ÔÊÉÓëp300Ãð»î/ VpS34È¥ÒÒõ£»¯ÃÜÇÐÓйأ¬Ñо¿ÈËÔ±·¢ÏÖÕâÓÐÀûÓÚ¸Îϸ°ûÖÐÖ¬µÎµÄÇå³ý¡£Òò´Ë£¬p300ÒÀÀµÐÔVpS34ÒÒõ£»¯/È¥ÒÒõ£»¯ÊÇVpS34¼¤»îµÄ¹Ø¼üÉúÀíÌõ¼þ£¬ÕâÖÖÐÞÊε÷¿ØÁ˵äÐÍÐÔ×ÔÊɺͷǵäÐÍÐÔ×ÔÊɵįô¶¯£¬ÆäÖÐVpS34µÄÉÏÓμ¤Ã¸¿ÉÒÔ±»ÈÆ¿ª¡£

ͬÆÚÖпÆÔºÕźêÑо¿×éÒ²ÔÚMolecular CellÔÓÖ¾ÉÏ·¢ÎÄ£¬²ûÊöÁ˶àϸ°ûÉúÎïÌØÓеÄ×ÔÊɵ°°×EpG-3/VMp1²ÎÓëÄÚÖÊÍø£¨ER£©µ÷¿Ø×ÔÊÉСÌåÐγɹý³ÌµÄ»úÖÆ¡£

Ñо¿ÈËÔ±·¢ÏÖEpG-3/VMp1¶¨Î»ÓÚÄÚÖÊÍøÉÏ£¬µ÷¿ØER-IMµÄÏ໥×÷Óá£VMp1ȱʧ»áµ¼ÖÂIMÓëERµÄÎȶ¨½áºÏ£¬´Ó¶ø×è¶Ï×ÔÊÉСÌåµÄÕý³£ÐγÉ¡£ÎÒÃÇ»¹·¢ÏÖWIpI2×÷ΪÏνӵ°°×£¬ÓëULK1 / FIp200¸´ºÏÌå¼°pI(3)pµÄÏ໥×÷Ó㬰ïÖúER-IM»¥×÷µÄ½¨Á¢ºÍά³Ö£¬ÔÚVMp1ȱʧϸ°ûÖÐÕâЩÏ໥×÷ÓÃÏÔÖøÔöÇ¿¡£³ýÁËER-IM»¥×÷Í⣬VMp1»¹¿ÉÒԹ㷺µ÷½ÚERÓëÆäËûϸ°ûÆ÷£¬°üÀ¨Ö¬µÎ£¨LD£©¡¢ÏßÁ£ÌåºÍ°ûÄÚÌåµÄÏ໥×÷Óá£Õâ²»½ö½ÒʾÁËER-IM »¥×÷½¨Á¢¼°½âÀëµÄ»úÖÆ£¬Ò²²ûÃ÷ÁËVMp1ͨ¹ýµ÷½ÚSERCAµÄ»îÐÔ¸ºÏàµ÷¿ØERÓëÆäËûϸ°ûÆ÷µÄ»¥×÷¡£ÄÚÖÊÍøÈçºÎµ÷¿Ø×ÔÊÉСÌåÐγÉ

£¨ÉúÎïͨ£ºÍòÎÆ£©

×÷Õß¼ò½é£º

Áõΰ Õã½­´óѧÇóÊÇÌØÆ¸½ÌÊÚ

1987Äê±ÏÒµÓÚµÚËľüÒ½´óѧ¿Õ¾üҽѧϵ£¬1998ÄêÔÚÈÕ±¾Ãû¹ÅÎÝ´óѧ»ñҽѧ²©Ê¿Ñ§Î»¡£1998ÖÁ1999ÄêÔÚÃû¹ÅÎÝ´óѧ´Óʲ©Ê¿ºóÑо¿£¬1999ÄêÖÁ2001ÄêÈÎÈÕ±¾°®ÖªÒ½¿Æ´óѧÖúÀí½ÌÊÚ£¬Ö÷Òª´ÓÊÂÖ×Áöϸ°ûÐźÅתµ¼ºÍϸ°ûµòÍö·½ÃæÑо¿¡£2001ÄêÖÁ2007ÄêÔÚÃÀ¹ú¹ú¼ÒÎÀÉúÑо¿Ôº£¨NIH£©ÃÀ¹ú¿ÆÑ§ÔºÔºÊ¿Jennifer Lippincott-SchwartzʵÑéÊÒ£¬¿ªÕ¹ÁËϸ°ûÄÚÄÒÅÝÔËÊäºÍ¸ß¶û»ùÌå½á¹¹¼°¹¦ÄÜÑо¿£¬ÔËÓÃGFpºÍʵʱ¶¯Ì¬Ó«¹âƯ°×µÈϸ°ûÄÚ¿ÉÊÓ»¯ÊֶΣ¬ÔÚ»îϸ°ûÄÚϵͳÑо¿ÁËÄÒÅݰü±»¸´ºÏÌåµÄ¶¯Á¦Ñ§£¬Ìá³öÁËеÄCOpI coatÔڸ߶û»ùÌåĤÉÏÐγɺͽâ¾ÛÄ£ÐÍ¡£2007ÄêÊÜÆ¸Õã½­´óѧҽѧԺ½ÌÊÚ¡¢²©Ê¿Éúµ¼Ê¦£¬½¨Á¢ÁËÒÔϸ°ûÆ÷½á¹¹ºÍ¹¦ÄÜΪÑо¿ÖÐÐĵÄϸ°ûÆ÷ÉúÎïѧʵÑéÊÒ¡£Ä¿Ç°µÄÖ÷ÒªÑо¿·½ÏòÊÇϸ°û×ÔÊɵķÖ×Óϸ°ûѧ»úÖÆºÍ×ÔÊÉÓëÖ×ÁöµÄ·¢Éú¡£Æù½ñÔÚ¹ú¼ÊÖøÃû¿¯ÎïÈçNature, Nat Struct Mol Biol, Mol Cell, J Cell Biol, Autophagy, HepatologyµÈ¹²·¢±íÑо¿ºÍ×ÛÊöÆÀÂÛÎÄÕÂ50ƪ£¬Ó°ÏìÒò×Ó×ÜÊý³¬¹ý320£¬±»ËûÒý³¬¹ý2000´Î¡£Ñо¿¹¤×÷µÃµ½Á˹ú¼ÒÖØµã»ù´¡Ñо¿¼Æ»®ºÍ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÖØµãÏîÄ¿µÄ×ÊÖú¡£ÏÖÈÎҽѧԺÉúÎﻯѧϵÖ÷ÈΣ¬Îª¡°Õã½­Ê¡ÓÐÍ»³ö¹±Ï×ÖÐÇàÄêר¼Ò¡±¡£

Ô­ÎıêÌ⣺

VpS34 Acetylation Controls Its Lipid Kinase Activity and the Initiation of Canonical and Non-canonical Autophagy